The U.S. Food and Drug Administration approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis.

Paolo Zamboni from Italy discovered that the draining veins from the brain (internal jugular veins) and from the spinal cord (azygous vein) are often blocked or narrowed.